Global 3D Medical Imaging Devices Market Trends Forecast 2024 - 2033
19 Apr, 2024
The 3D medical imaging devices market grew from $16.27 billion in 2023 to $17.23 billion in 2024, reflecting a CAGR of 5.9%, driven by improved diagnostic accuracy and aging populations. Projected to reach $21.67 billion in 2028, with a CAGR of 5.9%, factors include emerging markets, regulatory support, and the integration of AI and machine learning, alongside trends like liquid biopsies and point-of-care testing.
Major Driver In The 3D Medical Imaging Devices Market
The expansion of the 3D medical imaging market is primarily fueled by the surge in sports-related injuries. As participation in sports, especially high-strength training, continues to rise, there is a corresponding increase in severe injuries necessitating advanced diagnostic capabilities. 3D medical imaging devices such as ultrasound, X-ray, and MRI play a pivotal role in accurately diagnosing soft tissue injuries. For instance, in 2022, the Center for Disease Control and Prevention reported a staggering 775,000 emergency room visits for sports-related injuries in children, underscoring the critical need for accurate and objective injury diagnosis facilitated by 3D medical imaging devices, thereby supporting market growth.
Request A Free Sample Of The Global 3D Medical Imaging Devices Market Report3D Medical Imaging Devices Market Competitive Landscape
GE Healthcare, Royal Philips, Siemens AG, The Esaote Group, Materialise NV, Toshiba Group, Samsung Medison Co Ltd, Shimadzu Corporation, Analogic Corporation, Digirad Corporation, Del Medical Systems Group, Hologic Inc., Carestream Health Inc., Depuy Synthes Companies, Ambra Health, Fovia, Mach7 Technologies Ltd., Medtronic plc, Barco NV, TomTec Imaging Systems GmbH, Fujifilm Holdings Corporation, 3D Systems Healthcare, Artec 3D, Canon Medical Systems Corporation, ContextVision AB, Curvebeam AI Ltd., EchoPixel Inc., EOS Imaging, Esaote SpA, Hitachi Healthcare, Intrasense, KaVo Kerr, Konica Minolta Healthcare, Mobius Imaging, Neusoft Medical Systems, Orfit Industries, Pie Medical Imaging, Planmed Oy, Sectra, Shenzhen Mindray Bio-Medical Electronics, Thermo Fisher Scientific, Varian Medical Systems, Ziehm Imaging GmbH
Key 3D Medical Imaging Devices Market Trend
3D medical imaging device manufacturers are increasingly investing in Artificial Intelligence (AI) to enhance diagnosis accuracy, particularly in detecting organs or anomalies. For instance, GE Healthcare unveiled 60 innovative solutions, including AI, to transform healthcare by providing effective diagnostic solutions for patients and clinicians.
Get The Full Global 3D Medical Imaging Devices Market Report3D Medical Imaging Devices Market Segmentation
The 3D medical imaging devices market covered in this report is segmented –
1) By Type: Ultrasound, X-ray, CT Scan, Other Types
2) By Application: Gynecology and Obstetrics, Cardiology, Neurology, Orthopedics, Oncology
3) By End User: Diagnostic Centers, Hospitals, Research Centers
By Geography: The regions covered in the 3d medical imaging devices market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions
Western Europe was the largest region in the 3D medical imaging market in 2023. Asia-Pacific was the second-largest region in the global 3D medical imaging devices market. The regions covered in the 3d medical imaging devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
3D Medical Imaging Devices Global Market Report 2024 furnishes information about the global 3d medical imaging devicesmarket, encompassing details like market size, projections for growth, segmentation across various sectors and regions, and an overview of competitors, including their revenues, profiles, and market shares. Furthermore, the report pinpoints potential opportunities and strategic directions derived from market trends and the strategies adopted by key competitors. The report also offers an assessment of how the COVID-19 pandemic, the Russia-Ukraine conflict, and increasing inflation have affected both global and regional markets, furnishing valuable strategic insights for businesses.